should be included or not in DSM-5. 5 Those in favor claim that subjects with the syndrome exhibit deficits at a psychological, behavioral and cognitive level (possibly subthreshold), have the right and need to be treated. The widely accepted "neurodevelopmental theory" of schizophrenia provides an implicit theoretical foundation for early intervention during the pre-psychotic stage of the illness. The identification of individuals carrying unexpressed genetic liability to psychosis will be crucial for both etiological research and clinical risk stratification. Moreover, according to the "clinical stage model", the earlier in the course of illness treatment is offered the greater remission and recovery rates are. 1, 6 Those against emphasize the risk of stigmatization of people with minor psychopathology, the fact that only a minority will convert to psychosis in the following years and that antipsychotic medication in non-psychotic populations may be unethical. However, antipsychotic medication has already been used with good results in non-psychotic conditions, such as personality disorders (schizotypal, borderline, etc.) or behavioral disturbances (impulsivity, aggression, etc.). 7 Stigmatization of people with the syndrome could be avoided if the word "psychosis" dropped from the title. Therefore, our proposal is that this condition could be included in DSM-5 as a new category for further research with the title "Subthreshold Prodromal State". "Subthreshold" because of the decreased severity of psychotic symptoms, "Prodromal" both because the term has been associated with psychosis and because the subjects could manifest major psychopathology in the future and "State" because diagnosis may change with time. 
